Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.76 - $4.64 $35,024 - $58,881
-12,690 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.09 - $7.16 $51,902 - $90,860
12,690 New
12,690 $55,000
Q2 2021

Aug 16, 2021

SELL
$6.87 - $9.16 $371,357 - $495,143
-54,055 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$7.67 - $13.77 $414,601 - $744,337
54,055 New
54,055 $464,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $132M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.